An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients

Condition:   Renal Failure ChronicInterventions:   Drug: sevelamer carbonate 800mg;   Drug: sevelamer carbonate 2.4 gSponsor:   Genzyme, a Sanofi CompanyCompleted - verified January 2015

Source: ClinicalTrials.gov - December 16, 2014 Category: Research Source Type: clinical trials